The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis

Front Immunol. 2021 Jan 25:11:614976. doi: 10.3389/fimmu.2020.614976. eCollection 2020.

Abstract

T-cell epitope matching according to the TCE3 algorithm classifies HLA-DPB1 mismatches in permissive and non-permissive. This classification has been shown to be predictive for mortality and acute GvHD (aGvHD) events in large international cohorts. We retrospectively genotyped HLA-DPB1 in 3523 patients transplanted in Germany between 2000 and 2014 and in their unrelated donors using an Illumina amplicon-NGS based assay. Aim of the study was to evaluate DP-compatibility beyond the established TCE3 algorithm by assessing the combined effect of several DP-mismatch parameters on post-transplant outcome. We implemented an extended DP-mismatch assessment model where TCE3, DP allotype expression with respect to rs9277534, mismatch vector and number of mismatches were conjointly taken into consideration. In this model, non-permissive HLA-DPB1 mismatches showed significantly increased aGvHD risk if they were accompanied by two HLA-DPB1 mismatches in GvH direction (HR: 1.46) or one mismatched highly expressed patient allotype (HR: 1.53). As previously reported, non-permissive HLA-DPB1 mismatches associated with a significantly higher risk of aGvHD and non-relapse mortality (HR 1.36 and 1.21, respectively), which in turn translated into worse GvHD and relapse free survival (HR 1.13). Effects on GvL and GvHD appeared strongest in GvH-directed non-permissive mismatches. Our study results support the consideration of additional HLA-DPB1 mismatch parameters along with the established TCE3 matching algorithm for refinement of future donor selection. In particular, our findings suggest that DP non-permissiveness associated with two HLA-DPB1 mismatches or at least on highly expressed mismatched patient allotype should be avoided.

Keywords: HLA-DPB1; HLA-DPB1 expression; HLA-DPB1-permissiveness; graft-versus-host-disease; stem cell transplantation.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3' Untranslated Regions / genetics
  • Adolescent
  • Adult
  • Aged
  • Alleles
  • Allografts
  • Bone Marrow Transplantation*
  • Child
  • Child, Preschool
  • Epitopes, T-Lymphocyte / immunology*
  • Female
  • Germany
  • Graft vs Host Disease / epidemiology
  • Graft vs Host Disease / etiology*
  • Graft vs Host Disease / immunology
  • Graft vs Leukemia Effect / immunology
  • HLA-DP beta-Chains / analysis*
  • HLA-DP beta-Chains / genetics
  • Histocompatibility Testing / methods
  • Histocompatibility*
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Kaplan-Meier Estimate
  • Lymphocyte Depletion
  • Male
  • Middle Aged
  • Models, Immunological*
  • Peripheral Blood Stem Cell Transplantation*
  • Polymorphism, Single Nucleotide
  • Retrospective Studies
  • Risk
  • Unrelated Donors
  • Young Adult

Substances

  • 3' Untranslated Regions
  • Epitopes, T-Lymphocyte
  • HLA-DP beta-Chains
  • HLA-DPB1 antigen